Investigation of meiotic organelle checkpoint functions by Drosophila Myt1

• Author(s) / Creator(s)

  • Ramya Varadarajan

• Meiosis in eukaryotes includes a developmentally programmed pre-meiotic G2 phase arrest before the onset of MI division mediated by inhibitory phosphorylation of Cdk1. There are two inhibitory kinases, Wee1 and Myt1. Myt1 mediated Cyclin B-Cdk1 regulation serves as a conserved mechanism for maintaining pre-meiotic oocyte arrest in many animal models. Earlier reports from the Campbell lab, however, have shown that loss of Myt1 activity affected multiple aspects of Drosophila spermatogenesis resulting in male sterility. The conserved meiotic checkpoint function of Myt1 was hypothesized to account for myt1 mutant male sterility, as Drosophila spermatocytes normally undergo a developmentally regulated pre-meiotic G2 phase arrest before MI. This possibility, however, has not been tested. Here I show that loss of Myt1 activity neither affects the timing of pre-meiotic G2 phase arrest nor the overall coordination of G2/MI transition. Instead, the phenotypic analysis of myt1 mutants indicated that Myt1 activity is required for structural integrity of a germline specific membranous cytoskeletal organelle called the fusome (or intercellular bridges). I found that inhibition of Cyclin A-Cdk1 during early spermatocyte development requires Myt1 activity to prevent fusomes from premature Cdk1 activation. Mis-regulation of Cyclin A-Cdk1 during spermatocyte development also perturbed premature centrioles dis-engagement, producing multipolar meiotic spindles resulting in aneuploidy of myt1 meiocytes. I conclude that the role of Myt1 during pre-meiotic G2 phase arrest of male meiosis is to regulate discrete checkpoint mechanisms that are used to spatially and temporally coordinate cytoplasmic organelle behavior with the nuclear events of meiotic progression that are triggered by Cdc25Twe-mediated Cdk1 activation, at G2/MI.

• Date created

  2015-09-28

• Subjects / Keywords

  • Myt1 kinase
  • Drosophila spermatogenesis
  • Fusome
  • 2015/09/28
  • Edmonton, Alberta, Canada

• Type of Item

  Book

• DOI

  https://doi.org/10.7939/R39P2WH56

• License

  THESES NON-EXCLUSIVE LICENSE Family Name: Given Name, Middle Name (if applicable): Full Name of University: Faculty, Department, School: Degree for which thesis was presented: Date Degree Awarded: Thesis Title: Date of Birth. It is optional to supply your date of birth. If you choose to do so please note that the information will be included in the bibliographicrecord for your thesis. In consideration of Library and Archives Canada making my thesis available to interested persons, I, ¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ hereby grant a non-exclusive license, for the full term of copyright protection, to Library and Archives Canada: to preserve, perform, produce, reproduce, translate theses and dissertations in any format, and to make available in print or online by telecommunication to the public for non-commercial purposes. I undertake to submit my thesis, through my university, to Library and Archives Canada. Any abstract submitted with the thesis will be considered to form part of the thesis. I represent and promise that my thesis is my original work, does not infringe any rights of others, and that I have the right to make the grant conferred by this non-exclusivelicense. If third party copyrighted material was included in my thesis for which, under the terms of the Copyright Act, written permission from the copyright owners is required I have obtained such permission from the copyright owners to do the acts mentioned in paragraph (a) above for the full term of copyright protection I retain copyright ownership and moral rights in my thesis, and may deal with the copyright in my thesis, in any way consistent with rights granted by me to Library and Archives Canada in this non-exclusivelicence. I further promise to inform any person to whom I may hereafter assign or license my copyright in my thesis of the rights granted by me to Library and Archives Canada in this non-exclusivelicence. Signature Date Effective date for use of this form: 2014-10-31 to 2015-03-31.